Capture recapture estimation of the prevalence of mild intellectual disability and substance use disorder

https://doi.org/10.1016/j.ridd.2014.01.018Get rights and content

Highlights

  • Patients with substance use disorder (SUD) and MID are found in a variety of settings.

  • Single source studies do not provide reliable prevalence rates for SUD and MID.

  • Capture recapture methods combine samples to obtain more reliable prevalence data.

  • Capture recapture methods can also be used with incomplete or selected samples.

Abstract

Persons with mild to borderline intellectual disability (MID) have been identified as a group at risk for substance use disorder (SUD). However, prevalence estimates of co-occurring SUD and MID rely largely on single source studies performed in selected samples. To obtain more reliable population estimates of SUD and MID, this study combines data from an Intellectual Disability Facility (IDF), and an Addiction Treatment Centre (ATC) in a semi-rural area in the Netherlands. Capture–recapture analysis was used to estimate the hidden population (i.e., the population not identified in the original samples). Further analyses were performed for age and gender stratified data. Staff members reported on 88 patients with SUD and MID in the IDF (4.0% of the IDF sample) and 114 in the ATC (5.2% of the ATC sample), with 12 patients in both groups. Only strata for males over 30 years provided reliable population estimates. Based on 97 patients in these strata, the hidden population was estimated at 215. Hence the estimated total population of males over 30 years old with MID and SUD was 312 (95% CI 143–481), approximately 0.16% (0.05–0.25%) of the total population of this age and gender group. This illustrates that while patients with co-occurring SUD and MID often receive professional help from only one service provider, single source data underestimate its prevalence, and thus underestimate treatment and service needs. Therefore, population prevalence estimations of co-occurring SUD and MID should be based on combined multiple source data.

Introduction

Little is known about the prevalence of substance use disorders (SUD) among persons with a mild or borderline intellectual disability (MID) (Carroll Chapman and Wu, 2012, McGillicuddy, 2006, VanDerNagel et al., 2011). This is problematic because in this group the use of psychoactive substances – such as alcohol, cannabis and other illicit drugs – is associated with high levels of substance misuse and addiction. Reliable estimations of population prevalence are needed to plan treatment capacity and develop strategies for prevention (Carroll Chapman and Wu, 2012, McGillicuddy, 2006, VanDerNagel et al., 2011). Though population-based studies into SUD and co-occurring MID are lacking, several smaller-n studies conducted in various clinical, residential, and community settings, have provided data on prevalence rates of substance use, misuse, or abuse by persons with intellectual disabilities. For instance, among patients from addiction treatment facilities, Westermeijer, Kemp, and Nugent (1996) found that 6% of them had mild ID. In a sample of persons (n = 122) with mild to moderate ID from local community agencies, McGillicuddy and Blane (1999) found that 21% were misusing alcohol. Didden, Embregts, Van der Toorn, and Laarhoven (2009) found that among a sample of 39 patients with MID admitted to a specialized inpatient treatment facility, 46% were substance misusers. Chaplin, Gilvarry, and Tsakanikos (2011) reported that among referrals to a psychiatric facility for ID, 29% were substance misusers (n = 115). Since these studies concern highly selected samples the prevalence rates cannot be generalized. Moreover, these studies do not specify substance use rates for relevant subgroups, such as gender and age based strata, even though SUD prevalence rates differ across these groups (Laar et al., 2011). Finally, prevalence data from single sources (e.g., treatment facilities) are limited since persons with MID and SUD can be referred to several types of facilities.

Under Dutch law, persons with MID and SUD are eligible for help from both an Intellectual Disability Facility (IDF) and an Addiction Treatment Centre (ATC). Persons with an IQ between 70 and 85 are also eligible for IDF support and treatment if they have significant impairments in adaptive behaviour and if they present with a range of psychosocial problems such as unemployment, financial problems, and social isolation. Many persons with MID do not need (or want) inpatient or outpatient institutional care and are thus missed in surveys in IDF samples (Ras, Woittiez, van Kempen, & Sadiraj, 2010). Since persons with MID and SUD also seem to be less likely to receive addiction treatment or to remain in treatment (Carroll Chapman and Wu, 2012, VanDerNagel et al., 2011), data from ATCs will not cover the total population with SUD and MID either. Thus, although persons with both MID and SUD are eligible for two types of support or treatment, it has been noted that many of them receive only one type of help or no help at all (VanDerNagel, Kiewik, & Didden, 2012). Hence, prevalence rates of co-occurring SUD and MID cannot be reliably estimated from single sources, such as ATCs or IDFs. Nevertheless, single source information has been used to estimate population prevalence, and has served as a basis for policy makers. For instance, in 2007 the Dutch Health Minister estimated – based on reports from IDFs – that in the Netherlands (total population about 16.8 million) (Centraal Bureau voor de Statistiek [Statistics Netherlands], 2007) there were ‘several hundreds’ of youth present with MID and SUD (Parliament Proceedings, 2007). From clinical experience and data of a survey among IDFs (VanDerNagel et al., 2011) we concluded that this is an underestimation of the true population rate of SUD and MID (VanDerNagel et al., 2011, VanDerNagel et al., 2012).

In the present study, we used the data from an ATC and an IDF, located in a semi-rural area in the eastern region of the Netherlands with approximately 600,000 inhabitants (Centraal Bureau voor de Statistiek [Statistics Netherlands], 2010). In a capture recapture analysis we estimated the total number of individuals with both MID and SUD in this region. To obtain information on relevant subgroups, we also performed age- and gender-based stratified analysis.

Section snippets

Overview

The capture recapture method estimates the number of individuals in a population using data from multiple and incomplete samples (Böhning, 2008, Brittain and Böhning, 2009, Chao, 2001). In its original biological application, a sample (n1) from a target population (N) is captured, marked and released while the second sample (n2) is recaptured later. An estimate of the total population size can then be obtained by dividing the number of marked individuals (n1) by the proportion of marked

Results

In the ATC, 34 staff members (58%) reported on 144 patients with MID and in the IDF, 25 staff members (68%) identified 106 patients with SUD. After screening for doubles and excluding patients for whom ID or SUD were not confirmed, the ATC list (n1) comprised 114 patients with ID. The IDF list (n2) included 88 patients. No significant differences were found between these samples in terms of age, gender, ethnicity or level of ID (mild versus borderline ID) (Table 1). Significantly more patients

Discussion

In the present study, we used two samples, one from an Intellectual Disability Service (IDF, n = 88) and one from an Addiction Treatment Centre (ATC, n = 114), to estimate the number of patients with MID and SUD in a semi-rural area in the Netherlands. To the best of our knowledge, it is the first to apply capture recapture analysis to estimate the prevalence of co-occurring MID and SUD. The percentages found in the IDF and ATC samples, namely 4.5% and 5.7% respectively, were lower compared to

Acknowledgements

ZonMW [The Netherlands Organisation for Health Research and Development] provided financial support (Grant nr. 31160202) but had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The authors thank Debbie Nieuwenhuis, Larissa ten Broeke, and Fatma Dilibüyük for their contributions to this study, and Louise Kemna for proofreading this manuscript. The authors report no

References (20)

There are more references available in the full text version of this article.

Cited by (14)

  • A national profile of substance use disorder among Medicaid enrollees on the autism spectrum or with intellectual disability

    2022, Disability and Health Journal
    Citation Excerpt :

    For example, the impacts of SUD on functioning may be greater among those with ASD,18 including extensive support needs in psychiatry, employment, financial management, relationships and sexual behavior, daytime activities, and household management,19 and potential for increased mortality risk.13 Calls for better assessment of prevalence and treatment of SUD among people with I/DDs,22 using a variety of data sources,23 with consistent definitions of SUD,9 have not been met. We continue to lack a nuanced understanding of SUD in people with I/DDs in the U.S.,24 such as identifying drug use patterns specific to these disability groups.

  • Substance use disorders in individuals with mild to borderline intellectual disability: Current status and future directions

    2015, Research in Developmental Disabilities
    Citation Excerpt :

    The inter-individual variability in vulnerability to developing SUD not only calls for more knowledge on prevalence and risk factors of SU in the total population of individuals with ID (Carroll Chapman & Wu, 2012; McGillicuddy, 2006), but also across specific high-risk groups within this population. With regard to the population prevalence of SU(D) among individuals with ID, research in larger samples of individuals with ID is needed to plan treatment capacity and develop strategies for prevention and early detection (Carroll Chapman & Wu, 2012; VanDerNagel et al., 2014). This research should include a variety of research methods, such as biomedical markers of SU, administrative data and multicentre studies (e.g., Connors & Maisto, 2003; Slayter, 2010; VanDerNagel et al., 2014).

View all citing articles on Scopus
View full text